Thromb Haemost 2002; 88(01): 157-158
DOI: 10.1055/s-0037-1613170
Scientific and Standardization Committee Communications
Schattauer GmbH

Recommendations for tPA Thrombolysis in Children

On behalf of the Scientific Subcommittee on Perinatal and Pediatric Thrombosis of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis
Marilyn J. Manco-Johnson
1   Mountain States Hemophilia Center, Aurora, CO, USA
,
E. F. Grabowski
2   Harvard Medical School & Massachusetts General Hospital, Pediatric Hematology/Oncology, Boston, MA, USA
,
M. Hellgreen
3   Sahlgrenska Hospital/East, Department of Obstetrics/Gynecology, Goteborg, Sweden
,
A. S. Kemahli
4   Ankara University, Department of Pediatrics, Ankara, Turkey
,
M. P. Massicotte
5   University of Toronto, Division of Hematology/Oncology, Toronto, ON, Canada
,
W. Muntean
6   University of Graz, Department of Pediatrics, Graz, Austria
,
M. Peters
7   Academic Medical Center, Department of Pediatrics, Amsterdam, The Netherlands
,
N. Schlegel
8   Hospital Robert Debre, Lab D’Hematologie Biologique, Paris, France
,
M. Wang
1   Mountain States Hemophilia Center, Aurora, CO, USA
,
U. Nowak-Göttl
› Author Affiliations
Further Information

Publication History

Received 15 April 2002

Accepted 15 April 2002

Publication Date:
09 December 2017 (online)

 

 
  • References

  • 1 Levy M, Benson LN, Burrows PE, Bentur Y, Strong DK, Smith J, Johnson D, Jacobson S, Koren G. Tissue plasminogen activator for the treatment of thromboembolism in infants and children. J Pediatr 1991; 118: 467-72.
  • 2 Farnoux C, Camard O, Pinquier D, Hurtaud-Roux M-F, Sebag G, Schlegel N, Beaufils F. Recombinant tissue-type plasminogen activator therapy of thrombosis in 16 neonates. J Pediatr 1997; 133: 137-40.
  • 3 Weiner GM, Castle V, DiPietro MA, Faix RG. Successful treatment of neonatal arterial thromboses with recombinant tissue plasminogen activator. J Pediatr 1998; 133: 133-6.
  • 4 Haire WD, Atkinson JB, Stephens LC, Kotulak GD. Urokinase versus recombinant tissue plasminogen activator in thrombosed central venous catheters: a double-blinded, randomized trial. Thromb Haemost 1994; 72: 543-7.
  • 5 Davis SN, Vermeulen L, Banton J, Schwartz BS, Williams EC. Activity and dosage of alteplase dilution for clearing occlusions of venous-access devices. Am J Health-Sys Pharm 2000; 57: 1039-45.